U.S. In Vitro Diagnostics Market worth 25.99 Billion USD by 2020 U.S. In Vitro Diagnostics Market worth 25.99 Billi | Page 14

TABLE OF CONTENTS
6
U. S. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE........................................... 43
• 6.1
INTRODUCTION............................................................................................................................................................... 44
• 6.2
REAGENTS....................................................................................................................................................................... 46
• 6.3
INSTRUMENTS................................................................................................................................................................. 47
• 6.3.1
FULLY AUTOMATED INSTRUMENTS............................................................................................................. 48
• 6.3.2
SEMI-AUTOMATED INSTRUMENTS.............................................................................................................. 49
• 6.3.3
OTHERS......................................................................................................................................................... 49
• 6.4
DATA MANAGEMENT SOFTWARE.................................................................................................................................... 50
• 6.5
SERVICES......................................................................................................................................................................... 51
7
U. S. IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY....................................................... 52
• 7.1
INTRODUCTION............................................................................................................................................................... 53
• 7.2
CLINICAL CHEMISTRY.................................................................................................................................................... 54
• 7.3
IMMUNOCHEMISTRY / IMMUNOASSAYS......................................................................................................................... 55
• 7.4
MICROBIOLOGY............................................................................................................................................................... 56
• 7.5
MOLECULAR DIAGNOSTICS( MDX)................................................................................................................................ 57
• 7.6
HEMATOLOGY.................................................................................................................................................................. 58
• 7.7
COAGULATION / HEMOSTASIS.......................................................................................................................................... 59
• 7.8
OTHER IVD TECHNOLOGIES............................................................................................................................................ 60
8
U. S. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION........................................................ 61
• 8.1
INTRODUCTION............................................................................................................................................................... 62
• 8.2
INFECTIOUS DISEASES................................................................................................................................................... 63
• 8.3
DIABETES......................................................................................................................................................................... 65
• 8.4
ONCOLOGY / CANCER....................................................................................................................................................... 66
• 8.5
CARDIOVASCULAR DISORDERS..................................................................................................................................... 67
• 8.6
ENDOCRINE DISORDERS................................................................................................................................................. 68
• 8.7
AUTOIMMUNE DISEASES................................................................................................................................................ 70
• 8.8
BONE & MINERAL-RELATED DISEASES.......................................................................................................................... 71
• 8.9
PULMONARY DISEASES.................................................................................................................................................. 72
• 8.10
OTHER APPLICATIONS.................................................................................................................................................... 73
sales @ marketsandmarkets. com www. marketsandmarkets. com
14